Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us Adaptive
featured in Nature Biotechnology 04/01/2013 Adaptive received extensive
coverage in the March issue of Nature Biotechnology as the publication covered
personalized, sequencing-based immune profiling startups. The article details
at length the science behind next-generation sequencing and how Adaptive’s
assays can be used for, among other things, diagnosing lingering leukemia and
lymphoma in patients. Click to download the full article. Previous Press
Release Clinical Relevance of Minimal Residual Disease in NEJM 03/28/2013 Next
Press Release Adaptive featured in Nature magazine 04/05/2013
Corporate/Research (855) 466-8667 Diagnostics (888) 522-8988 Immune Profiling
PlatformPlatform Overview Publications Products & ServicesLIFE SCIENCES
RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ® Pipeline DRUG DISCOVERY
Cellular Therapy Vaccines PartnershipsCancer Cellular Therapy Antigen Map
Biopharma Partnerships Strategic Collaborators About UsOur Story Culture
Careers News & Events Contact Us © Adaptive Biotechnologies. All Rights
Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy HIPAA
Policy Code of Conduct Patents & Trademarks Licenses